Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Inc (NASDAQ:TLRY) reported a narrowed net loss and a significant increase in net revenue for the second quarter ending November 30. The company's net loss decreased to US$46.2 million from US$61.6 million in the same period a year earlier, while its net revenue rose by 34% to US$193.8 million.

Tilray Brands narrows net loss but record revenue not enough to keep shares up

Tilray Brands Inc (NASDAQ: TLRY) is trending up in premarket trading on Tuesday after reporting its financial results for the second quarter. Tilray is expanding in alcoholic beverages Shareholders are content also because the cannabis company saw its alcoholic beverages revenue more than double to $47 million in Q2.

Cannabis stock Tilray pops on narrowed Q2 loss

Tilray Brands Inc.'s stock TLRY, +2.63% rose 0.4% in premarket trading on Tuesday after the cannabis and beverage company's adjusted loss beat estimates on record revenue. Tilray said its second-quarter loss narrowed to $46 million, or 7 cents a share, from a loss of $62 million, or 11 cents a share, in the year-ago quarter.

Tilray Brands stock up as it narrows net loss on record revenue

Record Q2 Net Revenue of $194 Million, Increases 34% Over the Prior Year Period Global Cannabis Leader with #1 Market Share in Canada and 31% Growth in Canadian Cannabis Net Revenue, Medical Cannabis Leader in Europe with 55% Growth in International Cannabis Net Revenue 5th Largest Craft Beer Brewer in the U.S. 1 , Positioned to Become Top 12 Beverage-Alcohol Company with 117% Increase in Beverage Alcohol Net Revenue Over the Prior Year Period On Track to Achieve $30-$35 Million in Annual Savings related to Integration of HEXO Acquisition Reiterates Financial Guidance for Fiscal Year 2024 Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for its second quarter of its fiscal year 2024 ended November 30, 2023.

Tilray Brands Delivers Record Q2 Fiscal 2024 Net Revenue

With its share price down 92% since its 2018 market debut, and now trading as a penny stock, there doesn't appear to be much hope left for cannabis producer Tilray Brands (NASDAQ: TLRY ) stock. Tilray is the largest cannabis producer in neighboring Canada and hopes ran high for the stock (pun intended).

Tilray's Downfall: Why TLRY Stock Isn't the High Investors Hoped For

Cronos Group

Curaleaf Holdings, Inc.

There finally seems to be light at the end of the tunnel for the cannabis industry. It's difficult to talk about the regulatory perspective.

The 3 Hottest Cannabis Stocks to Watch in 2024

Aurora Cannabis

Canopy Growth

Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed it's reviewing an August recommendation from the U.S. Department of Health and Human Services (HHS) to change the classification of marijuana to Schedule III from Schedule I under the Controlled Substances Act. In a letter to Rep.

Cannabis stocks mark second day of gains as DEA confirms its review of marijuana's Schedule I classification

Disney

Starbucks

Tesla

Uber

Vertex Pharmaceuticals

Gen Z stocks aren't typical, because the generation has a unique relationship with the stock market. Just like Gen Z is the first to grow up fully immersed in digitization and the Internet culture, active market investing and trading is just another fact of life for a sizeable subset.

Gen Z's Top Picks for 2024: 7 Trending Stocks Among Young Investors

Get a deeper insight into the potential performance of Tilray Brands, Inc. (TLRY) for the quarter ended November 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Wall Street's Insights Into Key Metrics Ahead of Tilray Brands, Inc. (TLRY) Q2 Earnings

Shares of Tilray (NASDAQ: TLRY ) rose slightly on Jan. 3 and overnight after the company announced RIFF Boost, a collection of beverages infused with cannabis compounds. However, since the markets opened this morning, TLRY stock has dropped about 3.5%.

Tilray (TLRY) Stock Pops on New Cannabis Drinks Brand

RIFF Releases Volume 2 of their Ready-to-Drink Infused Beverages Introducing: Vanilla Frost and Tropical Burst Featuring THC and CBG TORONTO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today debuts the new RIFF BOOST™ beverage collection, featuring two new ready-to-drink THC and CBG-infused drinks from premium cannabis brand, RIFF. The new RIFF BOOST drinks are available in two new flavours, Tropical Burst and Vanilla Frost, each infused with a blend of nano-emulsified cannabinoids containing 10mg THC and 10mg CBG, ginseng extract, and 30mg of naturally occurring caffeine from guarana extract.

Kick off the New Year with a ‘BOOST' from RIFF Cannabis

Amplify Seymour Cannabis ETF

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Altria

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cambria Cannabis ETF

Roundhill Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Cannabis investors are tired of waiting and losing money, but there are still reasons to be optimistic in the long term.

Investing In Cannabis? Stay Patient, Be Ready

Advanced Micro Devices

Bowlero Corp

DraftKings

Fisker Inc

SPDR S&P 500 ETF Trust

Meme stocks are a part of the new investment world and are always an interesting topic to revisit. The social media world has given a much greater voice and larger platform to the average investor, who doesn't have as many resources as a hedge fund for example.

The 7 Best Meme Stocks to Buy Now

Village Farms International

As the global cannabis industry continues to expand, with its value reaching an impressive $50 billion in 2023, Canadian marijuana stocks are becoming increasingly important to watch in the first quarter of 2024. The early adoption of legalization in Canada has given its companies a significant advantage, allowing them to extend their influence worldwide. This rapid growth and international expansion make Canadian cannabis stocks a focal point for investors in the upcoming quarter.

Investor's Guide: Top Canadian Cannabis Stocks for Q1 2024

Bitfarms Ltd

Canoo

Terawulf

Penny stocks can get the market's attention, if nothing else. These speculative plays offer exponential returns for the strong-of-heart and provide ample opportunities for traders.

The most active penny stocks at Marketbeat.com

How desperate have things become for cannabis stocks? Tilray (NASDAQ: TLRY ) announced two new edible chocolate products on Dec. 22.

Tilray Stock Looks to Dig Out of a Hole in 2024

Palantir Technologies

SoFi Technologies

We're days away from the end of an incredible year on Wall Street. All the major indexes are up by double-digit percentages as we close out 2023.

Market Movers: 3 Unstoppable Stocks Set to Soar in 2024

Standard Lithium Ltd

Wallbox NV

Penny stocks are a trading bet. They are favored by investors looking for some quick returns in a short time-frame who aren't risk-averse.

3 Millionaire-Maker Penny Stocks to Hold for 36 Months

The movement to legalize marijuana is gaining momentum across the globe. Aurora Cannabis and Tilray Brands are two of the most prominent players in the space.

Better Marijuana Stock: Aurora Cannabis or Tilray Brands?

Marijuana stock investors have been through a lot of obstacles these last few years. In 2022 the sector was just coming out of the pandemic and 2023 has been about rebuilding the sector. Still even with continued success there was increased volatile trading. Much of this volatile action is based on fears and hold-ups on regulatory concerns. For instance, there are some who fear an industry shut down due to a lack of reform. Also, cannabis is still federally illegal which has been the biggest cause of this volatility.

Cannabis Investors Are Focused On Top Canadian Marijuana Stocks

Hecla Mining

As an investor, I would like to start the year on a high note. There would be no better deal than having a few stocks in the portfolio that skyrocket in the first few months of the year.

3 Hot Penny Stocks That Can Double in the First Quarter of 2024

Tilray announced two new products in its Chowie Wowie edibles line. President Biden will issue new pardons for marijuana-related offenses.

Why Tilray Stock Is Rocketing Higher Today

High Tide

Nick Gastevich, aka CannaVestments, on Q3 earnings. Focusing on cash flow and profitability, avoiding dilution and adding further debt.

Cannabis Investors - What You Should Know

NEW YORK and LEAMINGTON, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its second quarter ended November 30, 2023 on January 9, 2024.

Tilray Brands, Inc. to Announce Second Quarter 2024 Financial Results on January 9, 2024

Chowie Wowie Introduces New Soft Caramel and Crunchy Praline Flavours Newly Formulated Classics include Top-Selling THC Milk Chocolate, and Balanced THC and CBD Milk Chocolate TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the expansion of its market-leading cannabis portfolio with the latest releases from its Canadian cannabis edible brand, Chowie Wowie ™. Joining the original best-selling chocolates from Chowie's edible selection, including Balanced Milk Chocolate and THC Milk Chocolate, the brand introduces two new members to the family, inspired by two classic flavours: Soft Caramel and Crunchy Praline.

Tilray Launches Cannabis-Infused Premium Belgian Chocolates With Chowie Wowie Edibles Brand

News for Tilray Brands Stock (TLRY)